OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A phase 1b randomised controlled trial of a glucagon-like peptide-1 and glucagon receptor dual agonist IBI362 (LY3305677) in Chinese patients with type 2 diabetes
Hongwei� Jiang, Shuguang Pang, Yawei Zhang, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 33
Hongwei� Jiang, Shuguang Pang, Yawei Zhang, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 33
Showing 26-50 of 33 citing articles:
Looking ahead to potential incretin combination therapies for nonalcoholic steatohepatitis in patients with diabetes
Lucia Brodosi, Maria Letizia Petroni, Giulio Marchesini
Expert Opinion on Pharmacotherapy (2023) Vol. 24, Iss. 9, pp. 989-1000
Closed Access | Times Cited: 5
Lucia Brodosi, Maria Letizia Petroni, Giulio Marchesini
Expert Opinion on Pharmacotherapy (2023) Vol. 24, Iss. 9, pp. 989-1000
Closed Access | Times Cited: 5
Challenging Clinical Perspectives in Type 2 Diabetes with Tirzepatide, a First-in-Class Twincretin
Richard J. MacIsaac, Gary Deed, Michael C dʼEmden, et al.
Diabetes Therapy (2023) Vol. 14, Iss. 12, pp. 1997-2014
Open Access | Times Cited: 5
Richard J. MacIsaac, Gary Deed, Michael C dʼEmden, et al.
Diabetes Therapy (2023) Vol. 14, Iss. 12, pp. 1997-2014
Open Access | Times Cited: 5
Incretin-based therapy: a new horizon in diabetes management
Malek Zarei, Navideh Sahebi Vaighan, Mohammad Hadi Farjoo, et al.
Journal of Diabetes & Metabolic Disorders (2024) Vol. 23, Iss. 2, pp. 1665-1686
Closed Access | Times Cited: 1
Malek Zarei, Navideh Sahebi Vaighan, Mohammad Hadi Farjoo, et al.
Journal of Diabetes & Metabolic Disorders (2024) Vol. 23, Iss. 2, pp. 1665-1686
Closed Access | Times Cited: 1
Pharmacotherapy for chronic obesity management: a look into the future
Mariana Abdel-Malek, Lisa Yang, Alexander D. Miras
Internal and Emergency Medicine (2023) Vol. 18, Iss. 4, pp. 1019-1030
Open Access | Times Cited: 3
Mariana Abdel-Malek, Lisa Yang, Alexander D. Miras
Internal and Emergency Medicine (2023) Vol. 18, Iss. 4, pp. 1019-1030
Open Access | Times Cited: 3
The Discovery and Development of Glucagon-Like Peptide-1 Receptor Agonists
Haowen Fang, Bing Niu, Qin Chen
Current Medicinal Chemistry (2023) Vol. 31, Iss. 20, pp. 2921-2943
Closed Access | Times Cited: 2
Haowen Fang, Bing Niu, Qin Chen
Current Medicinal Chemistry (2023) Vol. 31, Iss. 20, pp. 2921-2943
Closed Access | Times Cited: 2
Incretin impact on gastric function in obesity: physiology, and pharmacological, surgical and endoscopic treatments
Michael Camilleri
The Journal of Physiology (2024)
Closed Access
Michael Camilleri
The Journal of Physiology (2024)
Closed Access
Twin- und Trinkretine: Balanceakt zwischen Diabetes und Adipositas?
Ovidiu Alin Stirban
Info Diabetologie (2024) Vol. 18, Iss. 1, pp. 30-36
Closed Access
Ovidiu Alin Stirban
Info Diabetologie (2024) Vol. 18, Iss. 1, pp. 30-36
Closed Access
Avaliação de miRNAs circulantes e sua associação com remissão de diabetes mellitus tipo 2 em mulheres com obesidade submetidas à derivação gástrica em Y de Roux
Ana Cristina Martı́nez
(2024)
Open Access
Ana Cristina Martı́nez
(2024)
Open Access
Mazdutide Versus Dulaglutide for Weight Loss and Diabetes Management: Meta-Analysis of Randomized Clinical Trials
Hazem Ayesh, Suhail Ayesh, Kevin D. Niswender
American Journal of Therapeutics (2024) Vol. 31, Iss. 5, pp. e619-e622
Closed Access
Hazem Ayesh, Suhail Ayesh, Kevin D. Niswender
American Journal of Therapeutics (2024) Vol. 31, Iss. 5, pp. e619-e622
Closed Access
